Logo image of PPTA

PERPETUA RESOURCES CORP (PPTA) Stock Fundamental Analysis

NASDAQ:PPTA - Nasdaq - CA7142661031 - Common Stock - Currency: USD

13.71  +0.51 (+3.86%)

Fundamental Rating

3

Overall PPTA gets a fundamental rating of 3 out of 10. We evaluated PPTA against 154 industry peers in the Metals & Mining industry. PPTA has a great financial health rating, but its profitability evaluates not so good. PPTA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PPTA had negative earnings in the past year.
PPTA had a negative operating cash flow in the past year.
In the past 5 years PPTA always reported negative net income.
PPTA had a negative operating cash flow in each of the past 5 years.
PPTA Yearly Net Income VS EBIT VS OCF VS FCFPPTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

PPTA's Return On Assets of -17.71% is on the low side compared to the rest of the industry. PPTA is outperformed by 74.68% of its industry peers.
Looking at the Return On Equity, with a value of -19.25%, PPTA is doing worse than 66.88% of the companies in the same industry.
Industry RankSector Rank
ROA -17.71%
ROE -19.25%
ROIC N/A
ROA(3y)-21.26%
ROA(5y)-63.51%
ROE(3y)-24.24%
ROE(5y)-97.6%
ROIC(3y)N/A
ROIC(5y)N/A
PPTA Yearly ROA, ROE, ROICPPTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PPTA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PPTA Yearly Profit, Operating, Gross MarginsPPTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, PPTA has more shares outstanding
PPTA has more shares outstanding than it did 5 years ago.
There is no outstanding debt for PPTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PPTA Yearly Shares OutstandingPPTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PPTA Yearly Total Debt VS Total AssetsPPTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

PPTA has an Altman-Z score of 54.24. This indicates that PPTA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PPTA (54.24) is better than 94.81% of its industry peers.
There is no outstanding debt for PPTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 54.24
ROIC/WACCN/A
WACCN/A
PPTA Yearly LT Debt VS Equity VS FCFPPTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

PPTA has a Current Ratio of 5.95. This indicates that PPTA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PPTA (5.95) is better than 85.71% of its industry peers.
A Quick Ratio of 5.95 indicates that PPTA has no problem at all paying its short term obligations.
PPTA's Quick ratio of 5.95 is amongst the best of the industry. PPTA outperforms 86.36% of its industry peers.
Industry RankSector Rank
Current Ratio 5.95
Quick Ratio 5.95
PPTA Yearly Current Assets VS Current LiabilitesPPTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

PPTA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.84%.
EPS 1Y (TTM)-8.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

PPTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 108.17% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-0.46%
EPS Next 2Y-44.44%
EPS Next 3Y-88.73%
EPS Next 5Y108.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PPTA Yearly Revenue VS EstimatesPPTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 500M 1B
PPTA Yearly EPS VS EstimatesPPTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PPTA. In the last year negative earnings were reported.
Also next year PPTA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PPTA Price Earnings VS Forward Price EarningsPPTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PPTA Per share dataPPTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

A cheap valuation may be justified as PPTA's earnings are expected to decrease with -88.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-44.44%
EPS Next 3Y-88.73%

More info and screens

0

5. Dividend

5.1 Amount

PPTA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERPETUA RESOURCES CORP

NASDAQ:PPTA (5/23/2025, 2:27:50 PM)

13.71

+0.51 (+3.86%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-09 2025-05-09/amc
Earnings (Next)08-07 2025-08-07
Inst Owners37.16%
Inst Owner Change11.94%
Ins Owners0.43%
Ins Owner Change18.3%
Market Cap977.39M
Analysts82.22
Price Target20.1 (46.61%)
Short Float %4.79%
Short Ratio3.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-50.33%
Min EPS beat(2)-135.29%
Max EPS beat(2)34.64%
EPS beat(4)3
Avg EPS beat(4)-5.8%
Min EPS beat(4)-135.29%
Max EPS beat(4)50.98%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.43%
PT rev (3m)11.61%
EPS NQ rev (1m)-150%
EPS NQ rev (3m)-150%
EPS NY rev (1m)0%
EPS NY rev (3m)-35.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 9.53
P/tB 9.53
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0
BVpS1.44
TBVpS1.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.71%
ROE -19.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-21.26%
ROA(5y)-63.51%
ROE(3y)-24.24%
ROE(5y)-97.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.95
Quick Ratio 5.95
Altman-Z 54.24
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1214.01%
Cap/Depr(5y)876.26%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
EPS Next Y-0.46%
EPS Next 2Y-44.44%
EPS Next 3Y-88.73%
EPS Next 5Y108.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-66.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.36%
EBIT Next 3Y8.99%
EBIT Next 5Y76.53%
FCF growth 1Y-61.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.43%
OCF growth 3YN/A
OCF growth 5YN/A